Summit Therapeutics Cash Flow Statement
NASDAQ: SMMTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.59+0.42 (+2.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Summit Therapeutics free cash flow
In fiscal 2025, Summit Therapeutics generated -$322.9 million of operating cash flow and spent $657,000 on capital expenditures. That left free cash flow of -$323.6 million.
Summary generated from market data by MetaCap's automated system. Methodology
Summit Therapeutics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-01-31 |
|---|---|---|---|---|---|---|---|
| Net Income | -1.08B | -221.31M | -614.93M | -78.78M | -88.60M | -52.70M | 10.87M |
| Net Income growth (YoY) | — | — | — | — | — | -584.84% | — |
| Depreciation & Amortization | 146.00K | 89.00K | 198.00K | 349.00K | 330.00K | 302.00K | 409.00K |
| Stock-Based Compensation | 732.42M | 50.98M | 14.11M | 11.95M | 12.80M | 1.77M | 6.29M |
| Change in Working Capital | 23.36M | 16.36M | -3.18M | -5.44M | 1.52M | 7.20M | -51.69M |
| Operating Cash Flow | -322.93M | -142.11M | -76.76M | -41.58M | -72.59M | -48.11M | -35.11M |
| Capital Expenditures | -657.00K | -139.00K | -128.00K | -624.00K | -306.00K | -421.00K | -157.00K |
| Investing Cash Flow | -174.31M | -205.34M | -587.77M | -624.00K | -306.00K | -421.00K | -331.00K |
| Dividends Paid | — | — | — | — | — | 0 | 0 |
| Financing Cash Flow | 617.53M | 381.23M | 86.51M | 620.24M | 77.92M | 50.55M | 44.51M |
| Net Change in Cash | 120.39M | 33.76M | -577.18M | 576.82M | 5.37M | 2.58M | 6.75M |
| Free Cash Flow | -323.59M | -142.25M | -76.89M | -42.21M | -72.89M | -48.53M | -35.26M |
This table shows 7 annual periods of Summit Therapeutics's cash flow statement, from FY 2025 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SMMT's reporting calendar. What is a cash flow statement?